Paul Gadiock Counsel
Wilson Sonsini Goodrich & Rosati

Paul Gadiock is counsel in the San Francisco office of Wilson Sonsini Goodrich & Rosati, where his practice primarily focuses on representing medical device companies, small and large alike, in efficiently navigating local and national regulatory requirements. He brings unique first-hand experience with the development and application of regulatory programs to counsel clients at all stages of the medical product life cycle. Paul provides premarket and postmarket regulatory solutions for medical product clients. Previously, he served on the senior leadership team at the Center for Devices and Radiological Health of the U.S. Food and Drug Administration (FDA). In this role, he advised key agency officials on issues related to the application of policies, programs, regulations, and legislation and was instrumental in appropriately encompassing or excluding devices from the scope of medical product regulation. Paul also minimized legal risk in Government Accountability Office (GAO) and Office of Inspector General (OIG) investigations, major national programs such as unique device identification (UDI), and medical device cybersecurity, as well as specific matters involving petitions and appeals to the FDA. In addition, he conducted numerous presentations and trained staff on how to streamline complex processes to reduce costs. Before his directorship role at the FDA, Paul served as a business development executive at a national diagnostic biotechnology company, advising international directors on how the company could comply efficiently, leading to cost-effective development of products that could be marketed in multiple countries with different regulatory requirements. Paul united scientists and sales teams to develop an extensive strategy that enhanced the company’s image and visibility by launching aggressive marketing campaigns.